You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR MUTAMYCIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MUTAMYCIN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003018 ↗	S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer	Completed	National Cancer Institute (NCI)	Phase 2	1997-09-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Chemotherapy following surgery may be an effective treatment for pancreatic cancer. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with stage II or stage III pancreatic cancer that has not been surgically removed.
NCT00003018 ↗	S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer	Completed	Southwest Oncology Group	Phase 2	1997-09-01	RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. Chemotherapy following surgery may be an effective treatment for pancreatic cancer. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with stage II or stage III pancreatic cancer that has not been surgically removed.
NCT00734994 ↗	Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer	Completed	Mark Dewhirst	Early Phase 1	2008-04-01	Hypothesis: In selected patients external hyperthermia will be used in combination with intravesical Mitomycin-C (MMC) to treat recurrent transitional cell carcinoma (TCC) of the bladder after local resection and standard adjuvant therapy and thus prevent or delay recurrence and the need for radical cystectomy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MUTAMYCIN

Condition Name

Chart
Table

Condition Name for MUTAMYCIN
Intervention	Trials
Stage IIIA Bladder Cancer AJCC v8	3
Stage III Bladder Cancer AJCC v8	3
Stage II Bladder Cancer AJCC v8	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MUTAMYCIN
Intervention	Trials
Carcinoma	7
Urinary Bladder Neoplasms	5
Carcinoma, Transitional Cell	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MUTAMYCIN

Trials by Country

Map
Table

Trials by Country for MUTAMYCIN
Location	Trials
United States	191
Mexico	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MUTAMYCIN
Location	Trials
Ohio	6
Michigan	6
Kentucky	6
California	6
Minnesota	6
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MUTAMYCIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MUTAMYCIN
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	3
Phase 2	9
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MUTAMYCIN
Clinical Trial Phase	Trials
Completed	5
Recruiting	4
Not yet recruiting	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MUTAMYCIN

Sponsor Name

Chart
Table

Sponsor Name for MUTAMYCIN
Sponsor	Trials
National Cancer Institute (NCI)	11
Mayo Clinic	2
ECOG-ACRIN Cancer Research Group	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MUTAMYCIN
Sponsor	Trials
Other	12
NIH	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.